Nidan Laboratories Peer Comparison

NSE: NIDAN

₹13.85

₹0.00 (0.00%)

As on 10-Sep-2026 10:12IST

Market cap

₹19 Cr

Revenue (TTM)

₹25 Cr

P/E Ratio

12.8

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Market cap (₹ Cr)	19	39,786	32,122	32,218	15,417
Revenue (₹ Cr)	25	4,683	4,213	2,891	857
Net Profit (₹ Cr)	1.98	552.34	190.80	546.30	187.49
Net Margin (%)	7.38	11.55	4.49	18.23	21.32
RoE (%)	2.94	14.93	9.45	23.03	20.58
Price to Earnings	12.78	71.54	157.23	59.45	82.23
Price-To-Book	0.28	9.68	8.49	12.33	15.31

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Operating Revenue	24.53	3,692.35	3,035.10	2,461.40	681.39
Total Income	26.78	3,797.15	3,067.00	2,554.83	699.71
Total Expenditure	19.47	2,831.90	2,242.10	1,765.80	408.17
EBITDA	5.06	860.44	793.00	695.60	273.22
Depreciation	2.41	193.75	177.20	141.92	70.60
EBIT	2.65	666.69	615.80	553.67	202.62
Interest	2.14	74.35	100.40	22.31	26.74
Other Income	2.25	104.81	31.90	93.43	18.32
Exceptional Items	--	-49.90	10.80	--	-1.03
Profit before Tax	2.76	647.26	558.10	624.80	193.16
Provision for Tax	0.78	165.94	143.30	132.55	49.37
Profit after Tax	1.98	481.32	414.80	492.25	143.79

Liabilities (₹ Cr)

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Shareholder's Funds	68.18	3,386.41	2,137.80	2,172.72	799.14
Minority Interest	--	1.10	281.00	33.76	--
Non-Current Liabilities	3.79	726.88	2,421.10	21.34	311.86
Current Liabilities	10.20	618.82	836.20	402.35	162.61
Total Liabilities	82.94	4,766.23	5,689.20	2,713.41	1,273.62

Assets (₹ Cr)

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Non-Current Assets	70.97	3,200.08	4,978.80	1,266.66	966.41
Current Assets	11.20	1,533.12	697.30	1,363.51	307.21
Total Assets	82.94	4,766.23	5,689.20	2,713.41	1,273.62
Total Debt*	11.11	327.88	1,910.90	0.00	0.00
Net Current Assets	1.01	914.31	-138.90	961.16	144.59
Contingent Liabilities	0.01	88.77	83.80	10.59	0.13

Cashflow (₹ Cr)

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Cash From Operating Activities	2.28	623.76	581.80	568.89	224.47
Cash Flow from Investing Activities	-0.22	-720.94	-1,116.20	-303.16	-181.88
Cash from Financing Activities	-3.01	-97.23	543.10	-334.03	-52.05
Net Cash Inflow / Outflow	-0.95	-194.41	8.70	-68.31	-9.45

Ratios

Profitability Ratios

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
ROCE (%)	6.21	20.50	19.02	31.53	30.20
ROE (%)	2.94	15.31	20.92	25.15	19.99
ROA (%)	2.41	10.72	8.74	19.53	12.76
EBIT Margin (%)	29.81	26.14	27.18	32.06	42.79
Net Margin (%)	7.38	12.68	13.52	19.27	20.55
Cash Profit Margin (%)	17.88	18.28	19.51	25.76	31.46

Growth Ratios

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Revenue Growth (%)	1.45	12.74	21.49	10.54	24.39
EBIT Growth (%)	-20.43	9.24	24.83	16.31	20.61
Net Profit Growth (%)	161.16	0.68	23.49	35.87	20.19
EPS Growth (%)	161.16	0.65	24.03	35.99	20.67
Book Value Growth (%)	2.99	16.71	16.93	17.68	19.36

Valuation Ratios

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Price / Earnings	11.64	66.85	66.51	21.26	71.86
Price / Book Value	0.34	9.50	11.96	9.79	13.20
Dividend Yield (%)	0.00	0.04	0.00	0.97	0.20
EV/EBITDA	4.41	32.52	33.22	25.19	35.28
Market Cap (₹ Cr)	23.00	32,181.74	25,571.93	20,714.85	10,333.01

Solvency Ratios

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debt to Equity	0.16	0.10	0.89	0.00	0.00
Short term debt to equity ratio	0.10	--	0.06	--	--
Current Ratio	1.10	2.48	0.83	3.39	1.89
Quick Ratio	1.05	2.37	0.76	3.30	1.86
Interest Coverage	2.29	9.71	6.56	29.01	8.22

Operating Efficiency Ratios

	Nidan Laboratories	Global Health	Krishna Institute	Dr. Lal Pathlabs	Vijaya Diagno
Debtors to sales (%)	5.17	7.90	13.03	3.58	2.17
Asset Turnover	0.30	0.82	0.64	0.98	0.60
Receivable days	13.34	25.07	41.48	12.27	8.30
Inventory Days	6.32	6.62	6.82	5.45	2.71
Payable days	397.84	79.17	135.60	134.04	142.28
Cash Conversion Cycle	-378.19	-47.48	-87.31	-116.32	-131.27

Annual
Quarterly